Selected research
Market Analysis & Forecast
Global Cellular Therapy Products Market Analysis and Forecast 2026-2032
Market perspective
The global Cellular Therapy Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cellular Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cellular Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cellular Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cellular Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Cellular Therapy Products include Beike Biotechnology, Fujifilm Cellular Dynamics, Gilead Sciences, Golden Meditech, Guanhao Biotech, JCR Pharmaceuticals, Osiris, Vcanbio and Vericel Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Cellular Therapy Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cellular Therapy Products, also provides the sales of main regions and countries. Of the upcoming market potential for Cellular Therapy Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cellular Therapy Products sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cellular Therapy Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cellular Therapy Products sales, projected growth trends, production technology, application and end-user industry.
Cellular Therapy Products Segment by Company
Beike Biotechnology
Fujifilm Cellular Dynamics
Gilead Sciences
Golden Meditech
Guanhao Biotech
JCR Pharmaceuticals
Osiris
Vcanbio
Vericel Corporation
Novartis
Cellular Therapy Products Segment by Type
Stem Cell Type
Non-Stem Cell Type
Cellular Therapy Products Segment by Application
Hospital
Clinic
Others
Cellular Therapy Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cellular Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cellular Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cellular Therapy Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cellular Therapy Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cellular Therapy Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cellular Therapy Products sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Type
- Non-Stem Cell Type
Applications
- Hospital
- Clinic
- Others
Companies covered
- Beike Biotechnology
- Fujifilm Cellular Dynamics
- Gilead Sciences
- Golden Meditech
- Guanhao Biotech
- JCR Pharmaceuticals
- Osiris
- Vcanbio
- Vericel Corporation
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cellular Therapy Products Market by Type
- 1.2.1 Global Cellular Therapy Products Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Stem Cell Type
- 1.2.3 Non-Stem Cell Type
- 1.3 Cellular Therapy Products Market by Application
- 1.3.1 Global Cellular Therapy Products Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cellular Therapy Products Market Dynamics
- 2.1 Cellular Therapy Products Industry Trends
- 2.2 Cellular Therapy Products Industry Drivers
- 2.3 Cellular Therapy Products Industry Opportunities and Challenges
- 2.4 Cellular Therapy Products Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Cellular Therapy Products Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Cellular Therapy Products Revenue by Region
- 3.2.1 Global Cellular Therapy Products Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cellular Therapy Products Revenue by Region (2021-2026)
- 3.2.3 Global Cellular Therapy Products Revenue by Region (2027-2032)
- 3.2.4 Global Cellular Therapy Products Revenue Market Share by Region (2021-2032)
- 3.3 Global Cellular Therapy Products Sales Estimates and Forecasts 2021-2032
- 3.4 Global Cellular Therapy Products Sales by Region
- 3.4.1 Global Cellular Therapy Products Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Cellular Therapy Products Sales by Region (2021-2026)
- 3.4.3 Global Cellular Therapy Products Sales by Region (2027-2032)
- 3.4.4 Global Cellular Therapy Products Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Cellular Therapy Products Revenue by Manufacturers
- 4.1.1 Global Cellular Therapy Products Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Cellular Therapy Products Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Cellular Therapy Products Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cellular Therapy Products Sales by Manufacturers
- 4.2.1 Global Cellular Therapy Products Sales by Manufacturers (2021-2026)
- 4.2.2 Global Cellular Therapy Products Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Cellular Therapy Products Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Cellular Therapy Products Sales Price by Manufacturers (2021-2026)
- 4.4 Global Cellular Therapy Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Cellular Therapy Products Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Cellular Therapy Products Manufacturers, Product Type & Application
- 4.7 Global Cellular Therapy Products Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Cellular Therapy Products Market CR5 and HHI
- 4.8.2 2025 Cellular Therapy Products Tier 1, Tier 2, and Tier 3
5 Cellular Therapy Products Market by Type
- 5.1 Global Cellular Therapy Products Revenue by Type
- 5.1.1 Global Cellular Therapy Products Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Cellular Therapy Products Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Cellular Therapy Products Revenue Market Share by Type (2021-2032)
- 5.2 Global Cellular Therapy Products Sales by Type
- 5.2.1 Global Cellular Therapy Products Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Cellular Therapy Products Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Cellular Therapy Products Sales Market Share by Type (2021-2032)
- 5.3 Global Cellular Therapy Products Price by Type
6 Cellular Therapy Products Market by Application
- 6.1 Global Cellular Therapy Products Revenue by Application
- 6.1.1 Global Cellular Therapy Products Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Cellular Therapy Products Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Cellular Therapy Products Revenue Market Share by Application (2021-2032)
- 6.2 Global Cellular Therapy Products Sales by Application
- 6.2.1 Global Cellular Therapy Products Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Cellular Therapy Products Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Cellular Therapy Products Sales Market Share by Application (2021-2032)
- 6.3 Global Cellular Therapy Products Price by Application
7 Company Profiles
- 7.1 Beike Biotechnology
- 7.1.1 Beike Biotechnology Company Information
- 7.1.2 Beike Biotechnology Business Overview
- 7.1.3 Beike Biotechnology Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Beike Biotechnology Cellular Therapy Products Product Portfolio
- 7.1.5 Beike Biotechnology Recent Developments
- 7.2 Fujifilm Cellular Dynamics
- 7.2.1 Fujifilm Cellular Dynamics Company Information
- 7.2.2 Fujifilm Cellular Dynamics Business Overview
- 7.2.3 Fujifilm Cellular Dynamics Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Fujifilm Cellular Dynamics Cellular Therapy Products Product Portfolio
- 7.2.5 Fujifilm Cellular Dynamics Recent Developments
- 7.3 Gilead Sciences
- 7.3.1 Gilead Sciences Company Information
- 7.3.2 Gilead Sciences Business Overview
- 7.3.3 Gilead Sciences Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Gilead Sciences Cellular Therapy Products Product Portfolio
- 7.3.5 Gilead Sciences Recent Developments
- 7.4 Golden Meditech
- 7.4.1 Golden Meditech Company Information
- 7.4.2 Golden Meditech Business Overview
- 7.4.3 Golden Meditech Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Golden Meditech Cellular Therapy Products Product Portfolio
- 7.4.5 Golden Meditech Recent Developments
- 7.5 Guanhao Biotech
- 7.5.1 Guanhao Biotech Company Information
- 7.5.2 Guanhao Biotech Business Overview
- 7.5.3 Guanhao Biotech Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Guanhao Biotech Cellular Therapy Products Product Portfolio
- 7.5.5 Guanhao Biotech Recent Developments
- 7.6 JCR Pharmaceuticals
- 7.6.1 JCR Pharmaceuticals Company Information
- 7.6.2 JCR Pharmaceuticals Business Overview
- 7.6.3 JCR Pharmaceuticals Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 JCR Pharmaceuticals Cellular Therapy Products Product Portfolio
- 7.6.5 JCR Pharmaceuticals Recent Developments
- 7.7 Osiris
- 7.7.1 Osiris Company Information
- 7.7.2 Osiris Business Overview
- 7.7.3 Osiris Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Osiris Cellular Therapy Products Product Portfolio
- 7.7.5 Osiris Recent Developments
- 7.8 Vcanbio
- 7.8.1 Vcanbio Company Information
- 7.8.2 Vcanbio Business Overview
- 7.8.3 Vcanbio Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Vcanbio Cellular Therapy Products Product Portfolio
- 7.8.5 Vcanbio Recent Developments
- 7.9 Vericel Corporation
- 7.9.1 Vericel Corporation Company Information
- 7.9.2 Vericel Corporation Business Overview
- 7.9.3 Vericel Corporation Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Vericel Corporation Cellular Therapy Products Product Portfolio
- 7.9.5 Vericel Corporation Recent Developments
- 7.10 Novartis
- 7.10.1 Novartis Company Information
- 7.10.2 Novartis Business Overview
- 7.10.3 Novartis Cellular Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Novartis Cellular Therapy Products Product Portfolio
- 7.10.5 Novartis Recent Developments
8 North America
- 8.1 North America Cellular Therapy Products Market Size by Type
- 8.1.1 North America Cellular Therapy Products Revenue by Type (2021-2032)
- 8.1.2 North America Cellular Therapy Products Sales by Type (2021-2032)
- 8.1.3 North America Cellular Therapy Products Price by Type (2021-2032)
- 8.2 North America Cellular Therapy Products Market Size by Application
- 8.2.1 North America Cellular Therapy Products Revenue by Application (2021-2032)
- 8.2.2 North America Cellular Therapy Products Sales by Application (2021-2032)
- 8.2.3 North America Cellular Therapy Products Price by Application (2021-2032)
- 8.3 North America Cellular Therapy Products Market Size by Country
- 8.3.1 North America Cellular Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Cellular Therapy Products Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Cellular Therapy Products Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Cellular Therapy Products Market Size by Type
- 9.1.1 Europe Cellular Therapy Products Revenue by Type (2021-2032)
- 9.1.2 Europe Cellular Therapy Products Sales by Type (2021-2032)
- 9.1.3 Europe Cellular Therapy Products Price by Type (2021-2032)
- 9.2 Europe Cellular Therapy Products Market Size by Application
- 9.2.1 Europe Cellular Therapy Products Revenue by Application (2021-2032)
- 9.2.2 Europe Cellular Therapy Products Sales by Application (2021-2032)
- 9.2.3 Europe Cellular Therapy Products Price by Application (2021-2032)
- 9.3 Europe Cellular Therapy Products Market Size by Country
- 9.3.1 Europe Cellular Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Cellular Therapy Products Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Cellular Therapy Products Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Cellular Therapy Products Market Size by Type
- 10.1.1 China Cellular Therapy Products Revenue by Type (2021-2032)
- 10.1.2 China Cellular Therapy Products Sales by Type (2021-2032)
- 10.1.3 China Cellular Therapy Products Price by Type (2021-2032)
- 10.2 China Cellular Therapy Products Market Size by Application
- 10.2.1 China Cellular Therapy Products Revenue by Application (2021-2032)
- 10.2.2 China Cellular Therapy Products Sales by Application (2021-2032)
- 10.2.3 China Cellular Therapy Products Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cellular Therapy Products Market Size by Type
- 11.1.1 Asia Cellular Therapy Products Revenue by Type (2021-2032)
- 11.1.2 Asia Cellular Therapy Products Sales by Type (2021-2032)
- 11.1.3 Asia Cellular Therapy Products Price by Type (2021-2032)
- 11.2 Asia Cellular Therapy Products Market Size by Application
- 11.2.1 Asia Cellular Therapy Products Revenue by Application (2021-2032)
- 11.2.2 Asia Cellular Therapy Products Sales by Application (2021-2032)
- 11.2.3 Asia Cellular Therapy Products Price by Application (2021-2032)
- 11.3 Asia Cellular Therapy Products Market Size by Country
- 11.3.1 Asia Cellular Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Cellular Therapy Products Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Cellular Therapy Products Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cellular Therapy Products Market Size by Type
- 12.1.1 SAMEA Cellular Therapy Products Revenue by Type (2021-2032)
- 12.1.2 SAMEA Cellular Therapy Products Sales by Type (2021-2032)
- 12.1.3 SAMEA Cellular Therapy Products Price by Type (2021-2032)
- 12.2 SAMEA Cellular Therapy Products Market Size by Application
- 12.2.1 SAMEA Cellular Therapy Products Revenue by Application (2021-2032)
- 12.2.2 SAMEA Cellular Therapy Products Sales by Application (2021-2032)
- 12.2.3 SAMEA Cellular Therapy Products Price by Application (2021-2032)
- 12.3 SAMEA Cellular Therapy Products Market Size by Country
- 12.3.1 SAMEA Cellular Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Cellular Therapy Products Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Cellular Therapy Products Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Cellular Therapy Products Value Chain Analysis
- 13.1.1 Cellular Therapy Products Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Cellular Therapy Products Production Mode & Process
- 13.2 Cellular Therapy Products Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Cellular Therapy Products Distributors
- 13.2.3 Cellular Therapy Products Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst